Top Precision Medicine Solution Companies
Pro Care Innovations (PCI): The Leading Chronic Care Management Enablers

Top 10 Precision Medicine Solution Companies - 2020

Precision medicine reflects an evolution in healthcare—moving away from the conventional one-size-fits-all approach. With a foundation built on a broad spectrum of information, it encompasses the utilization of traditional clinical information, new data, including genetic data, and advanced technologies to match the right treatment for a patient. Precision medicine relies on large quantities of data from population-based studies that can be sourced from genetic databases, medical records, tissue banks, and other big data channels. Considering the individual variability in genes, environment, and lifestyle from this data helps doctors predict more accurately which treatment strategy is suited for a particular person and the disease. Precision medicine also saves treatment costs and prevents unintended side effects possible in the broad treatment approach.

For now, precision medicine applications are primarily focused on treatment against oncological diseases, and it’s likely to continue in the near future. The increasing support from government initiatives is expected to accelerate the growth of the precision medicine market in oncological applications. With the genomic research scope widening, researchers are looking at non-oncology therapeutic areas as well. These include infectious diseases, nervous system disorders, and cardiovascular diseases. Further, the more specific research of pharmacogenomics that involves the study of genes’ response to drugs will expand with the growth of precision medicine.

Precision medicine is also playing a critical role in changing public opinion on utilizing data for treatment and providing increased transparency in diagnosis. The emphasis on consumer-based practices and widespread adoption of fitness tracking devices suggest public receptiveness toward personalized health and precision medicine. This will allow increased consumer involvement in healthcare decision-making processes and bring more clarity about treatment costs.

In light of these significant advancements today, Healthcare Tech Outlook has compiled a list of top 10 precision medicine solution providers and top 10 precision medicine consulting/services companies for 2020 to guide enterprise leaderships in harnessing the power of technology to embrace innovation and enhance productivity.

With exceptional technological acumen and numerous success stories up their sleeves, many of these companies have consistently proven their expertise in robust precision medicine solutions and services landscape worldwide. We hope this issue of Healthcare Tech Outlook helps you build the partnership you and your firm need to adopt efficient precision medicine solutions and services to enhance consumer experience and productivity.

We present to you Healthcare Tech Outlook’s Top 10 Precision Medicine Solution Providers — 2020.

Top Precision Medicine Solution Companies

Genomenonis a genomic health IT company that connects genomics research to patient DNA to help diagnose and develop precision medicines for patients with rare genetic diseases and cancer. The company provides a comprehensive genomic search platform named Mastermind to identify and analyze genetic evidence found across the complete corpus of scientific articles. The search results empower scientists and researchers at pharmaceutical companies, clinical labs, and universities across the globe to understand diseases at a molecular level. Genomenon was recently named the 2020 Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan for delivering comprehensive genomics data interpretation, resulting in more accurate diagnoses

www.genomenon.com

Pro Care Innovations is focused on delivering high-quality preventive medicine to its clients through Chronic Care Management. By enabling clinicians to provide preventive care to geriatric patients, PCI has created millions of dollars in new revenue to practices while reducing catastrophic events and increasing the country's geriatric population's life span. Having spent more than four years in the CCM space, PCI enables clinicians to adopt a "next level" CCM program. The company's all-inclusive program provides clients with the best patient outcomes and efficiency that is unmatched in the space. PCI works with clients to develop everything from patient marketing strategies and diagnostic-based templates to assure that patients get the focused care they deserve

www.procareinnovations.com

2bPrecise

2bPrecise

Founded in 2015, 2bPrecise was established to enable providers to leverage the value of genomic data at the point of care. With deep expertise in data models, complex ontologies and clinical integration, the 2bPrecise team created a cloud-based platform that can span extensive healthcare organizations to support their precision medicine strategies, now and into the future.2bPrecise is committed to bridging the gap between the science of genomics and making it meaningful within the clinical workflow. Allscripts Healthcare Solutions is the primary investor in 2bPrecise

BillionToOne

BillionToOne

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level

Genome Medical

Genome Medical

Genome Medical is a nationwide medical practice and efficient genomic services network providing high quality genomic medicine consultations and genetic counseling services. We bridge the gap between genome technology and medical practice by serving both physicians and patients to move us toward a more genome-centered healthcare system

Karius

Karius

Karius is a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive Karius® Test that helps clinicians make rapid treatment decisions. Karius sees a world where infectious disease is no longer a major threat to human health. To achieve this, the Karius Test enables mapping of the patient’s microbial landscape from a single blood sample to enable physicians to make rapid treatment decisions

LifeOmic

LifeOmic

LifeOmic is the software company that leverages the cloud, machine learning and mobile devices to offer disruptive solutions to healthcare providers, researchers, employers, health coaches, health IT companies and individuals. LifeOmic was founded in late 2016 by serial entrepreneurial Dr. Don Brown and several other key employees from Interactive Intelligence. We believed in the promise of Precision Health but saw a large gap in the current healthcare IT landscape and its ability to fulfill this promise. Leveraging our cloud and mobile software expertise, we set out to drive better health outcomes for individuals. Now 2020, our 90+ team members work with some of the largest and most respected healthcare and biotech organizations to accelerate their research and help clinicians deliver better patient outcomes. Our Precision Health Cloud drives innovation in precision medicine and puts data to work for patient outcomes. We also help individuals take control of their health through our suite of mobile applications and science-backed, educational health content on LIFE Apps

OneOme

OneOme

OneOme, co-founded by Mayo Clinic, is working to help providers incorporate pharmacogenomics into patient care by offering the RightMed Test and associated tools. The RightMed Test may help providers optimize medication selection for their patients by analyzing and reporting on 27 genes

Syapse

Syapse

Syapse works with leading health systems, life sciences companies, and regulators to accelerate real-world evidence to improve the outcomes of cancer patients. By bringing these organizations together into the Syapse Learning Health NetworkTM, Syapse has built one of the world’s largest networks dedicated to improving outcomes in cancer care through improved precision medicine. Syapse and its partners are working towards a future in which all cancer patients have access to the quality of care they need

TIGAR Health

TIGAR Health

TIGAR Health delivers a personalized medicine solution to provide more effective treatment of Type 2 diabetes and prediabetes. We analyze the patient's underlying metabolic regulatory pathways, and then integrate it with experts’ decision rules, patient patterns and key anti-diabetic drug information. In doing so, we transform metabolic medicine through personalized therapy regimens for each patient. Through our approach we can pick up undiagnosed conditions which are missed today, providing a more informed view of the patient. TIGAR reduces the complexity in choosing the right drugs by removing the trial and error method used today. Our individualized approach frees up time for a physician to interact with patients and leads the patient to fuller engagement and better health. We motivate patients by illuminating their underlying disease, and showing the best treatment strategies to address a patient’s situation